A Randomized, Open-label, Parallel Study to Evaluate the Efficacy and Safety of Oral Navelbine in Female Patients With HER2-Negative Metastatic Breast Cancer
Latest Information Update: 27 Sep 2023
At a glance
- Drugs Vinorelbine (Primary)
- Indications Advanced breast cancer; HER2 negative breast cancer
- Focus Therapeutic Use
Most Recent Events
- 01 Mar 2019 New trial record